An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSMSybil Hosek, Peter L. Anderson, Jennifer J. Kiser et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016Cited by 278
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United StatesSybil Hosek, Craig M. Wilson, Raphael J. Landovitz et al.|JAMA Pediatrics|2017Cited by 226
Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral TherapyPatricia M. Flynn, Jane C. Lindsey, Bret J. Rudy et al.|The Journal of Infectious Diseases|2004Cited by 101
Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-UpPatricia M. Flynn, Bret J. Rudy, Jane C. Lindsey et al.|AIDS Research and Human Retroviruses|2007Cited by 65
Peripheral Blood Lymphocyte Subsets in Adolescents: a Longitudinal Analysis from the REACH ProjectBret J. Rudy, Steven D. Douglas, Craig M. Wilson et al.|Clinical and Vaccine Immunology|2002Cited by 63